Top

Published in:

01-12-2018 | ASO Author Reflections

ASO Author Reflections: Eighty is the New Sixty—Breast Cancer Treatment Strategies in the Octogenarian Patient Population

Author: Ranjna Sharma, MD

Published in: Annals of Surgical Oncology | Special Issue 3/2018

Excerpt

As the population ages and life expectancy increases, many women are living longer, healthier lives.1 Breast cancer diagnoses are also on the rise in older populations given this longevity.2 It has been estimated that 12% of the population will develop breast cancer over the course of their lifetimes, with women aged 65 years and over at greatest risk as increasing age is a known risk factor for the development of breast cancer. Historically, octogenarians have not been included in research studies examining oncologic therapy efficacy in robust numbers. Thus, it is challenging to know what therapies may be effective and necessary to treat breast cancer in this patient population.2,3 …

Barginear MF, Muss H, Kimmick G, et al. Breast cancer and aging: results of the U13 conference breasts cancer panel. Breast Cancer Res Treat. 2014;146(1):1–6.CrossRefPubMedPubMedCentral

Schonberg MA, Silliman, RA, McCarthy EP, Marcantonio ER. Factors noted to affect women aged 80 and older’s breast cancer treatment decisions. Breast Cancer Res Treat. 2014;145(1):211–23.CrossRefPubMedPubMedCentral

Cortadellas T, Gascon A, Cordoba O, et al. Surgery improves breast cancer-specific survival in octogenarians with early-stage breast cancer. Int J Surg. 2013;11(7): 554–7.CrossRefPubMed

Mamtani A, Gonzalez JJ, Neo DT, et al. Treatment strategies in octogenarians with early-stage, high-risk breast cancer. Ann Surg Oncol. 2018;25:1495–501.CrossRefPubMedPubMedCentral

Mamtani A, Gonzalez JJ, Neo D, et al. Early-stage breast cancer in the octogenarian: tumor characteristics, treatment choices, and clinical outcomes. Ann Sur Oncol. 2016;23(10):3371–8.CrossRef

Wickberg A, Liljegren G, Killander F, et al. Omitting radiotherapy in women > 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe. Eur J Surg Oncol. 2018;44(7):951–6.CrossRefPubMed

Coates AS, Winer EP, Goldhirsch A, et al. Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the primary therapy of early breast cancer 2015. Ann Oncol. 2015;26(8):1533–46.CrossRefPubMedPubMedCentral

Title: ASO Author Reflections: Eighty is the New Sixty—Breast Cancer Treatment Strategies in the Octogenarian Patient Population
Author: Ranjna Sharma, MD
Publication date: 01-12-2018
Publisher: Springer International Publishing
Published in: Annals of Surgical Oncology / Issue Special Issue 3/2018
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-018-7071-8

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

ASO Author Reflections: Eighty is the New Sixty—Breast Cancer Treatment Strategies in the Octogenarian Patient Population

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Special Issue 3/2018

ASO Author Reflections: Systemic Inflammatory Markers in Pancreatic Neuroendocrine Tumors

ASO Author Reflections: Equitable High-Quality Cancer Surgery Care: Optimism, Pessimism, and Realism

ASO Author Reflections: Outcomes of Appendiceal Goblet Cell Carcinoid Tumors

ASO Author Reflections: Redefining the Ki-67 Index Stratification for Low-Grade Pancreatic Neuroendocrine Tumors

ASO Author Reflections: PD-1 Expression in Bacillus Calmette–Guérin-Relapsing Bladder Cancer

ASO Author Reflections: Changes in Use of Neoadjuvant Chemotherapy Over Time—Highest Rates of Use Now in Triple-Negative and HER2+ Disease